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THE INFLUENZA VIRUS ENZYME AND ITS MUCOPROTEIN SUBSTRATE*
With regard to size and enzymatic equipment viruses may be regarded as
representing the lowest level of life. Their size ranges from about 20 to
400 m,. Viruses do not grow on cell-free culture media; they multiply in
living cells, and only those cells are host cells whose membranes have
suitable adsorption areas for attachment of the virus particle and whose
metabolic processes can be directed into such channels as to provide the
material resources for the replication of virus genetic patterns. It is prob-
ably true to say that viruses have nothing like the elaborate enzymic equip-
ment of even the smallest bacteria; however, the statement that viruses are
devoid of enzymes is an oversimplification and certainly does not hold for
the influenza virus. Most intracellular enzymes have been discovered in the
past by allowing well-defined compounds, known to be metabolized by the
living cell concerned, to be acted upon by an appropriate extract of the cell
and then to investigate the chemical change induced, the variation of the
reaction rate with temperature, pH, ionic environment, etc. An enzyme will
remain undetected when no suggestion is available about the possible nature
of its substrate, since no sensible plan can be devised to test for the
unknown activity of an enzyme.
The first observation relevant to the existence of a viral enzyme was
made by Hirst.' He found that influenza virus is adsorbed to the surface of
erythrocytes and by forming bridges between the cells agglutinates them.
The existence of large aggregates underlying the pattern formation in influ-
enza virus haemagglutination implies that the virus particles and erythro-
cytes must be multivalent with regard to each other. Virus haemagglutina-
tion, being an adsorption phenomenon, proceeds readily at 00 C. If the red
cells with the influenza virus particles attached to them are brought to
370 C., spontaneous elution of the virus into the medium takes place.28 The
virus present in the medium is functionally intact and available for further
haemagglutination; the red cells, however, are irreversibly changed, having
lost their ability to adsorb virus. Hirst"8 interpreted this phenomenon in
terms of an enzyme-substrate interaction, the enzyme possessed by the virus
acting upon a receptor substance present at the surface of the red cell, an
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interaction followed by separation of the enzyme from the reaction products.
This interpretation was supported by Burnet's discovery9",0 of a soluble
enzyme in cultures of vibrio cholerae. The vibrio enzyme was shown to
imitate almost to the last detai Ithe effect of the virus on the red cell
receptors.'0 Other observations were reported, all of them difficult to under-
stand on any other basis than on Hirst's concept of virus enzyme-cellular
receptor interaction. Briody,5 for instance, found that influenza B virus
upon heating to 550 C. for 30 minutes is still adsorbed to and agglutinates
red cells, but fails to elute spontaneously. Hanig' and Ada and Stone2'
demonstrated a decrease in the electrophoretic mobility of human erythro-
cytes after treatment with influenza virus, different strains reducing the
mobility value to different levels. The largest decrease in electrophoretic
mobility was experienced when the red cells were treated with a purified
preparation of the enzyme obtained from vibrio cholerae cultures referred
to as receptor destroying enzyme (RDE). That both influenza virus and
RDE are acting upon the same chemical groupings of the receptor substance
embedded in the cell surface is indicated by the lack of any summation
effect on the electrophoretic mobility when RDE treatment of the erythro-
cytes is preceded by treatment with influenza virus.'
The same sequence of events described for the system influenza virus and
erythrocytes was observed when surviving host cells were substituted for
erythrocytes. Thus influenza virus is adsorbed to and spontaneously elutes
from the susceptible respiratory cells of the excised ferret' and mouse'
lung. Pretreatment with RDE renders the respiratory surface of the excised
mouse lung unable to adsorb influenza virus'8; indeed, infection of the
respiratory tract of the intact animal by inhaled influenza virus can be
prevented when preceded by RDE treatment,"2 just as influenza virus
infection of the chorio-allantoic membrane of the embryonated egg is hin-
dered after the lining cells have been exposed to the action of RDE." The
similarity of the point of attack on cellular receptors of the soluble vibrio
enzyme and the influenza virus particle could be demonstrated in many
other ways; red cells, for instance, the receptors of which have been altered
by one of the two agents fail to adsorb the other agent, and adsorption in
the cold of one agent onto the intact erythrocytes blocks the adsorption of
the other agent, as coating of the cells with one type of virus precludes the
adsorption of a second type.'0 Furthermore, treatment with influenza virus
as well as with the vibrio enzyme renders cells agglutinable by normal
human sera to equivalent titres.40
Another test object for the nature of the agent present at the influenza
virus surface and causing the loss of biological activity of certain cellular
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receptors was provided by the observation of Francis'6 that heating influ-
enza virus at 560 C. for 30 minutes allows normal serum to inhibit its
haemagglutinin. Anderson,8 in this Institute, discovered that the anti-
haemagglutinin activity of normal serum is lost on treatment by living
influenza virus or RDE. In addition to normal serum quite a number of
secretions of human or animal origin (human meconium, ovarian cyst
mucin, cervical mucus, respiratory mucus, sheep submaxillary glands
mucin, hen egg-white) were found to contain a potent virus haemagglutinin
inhibitor; again digestion with RDE or the infective influenza virus particle
destroyed irreversibly the biological activity of the inhibitors.8
The above results clearly demonstrated that in all essentials the action of
the influenza virus on red cell receptors, host cell receptors, and on haemag-
glutinin inhibitors is paralleled by an enzyme produced by cholera vibrio
strains. The data confirmed in every respect Hirst's suggestion of the
presence of an enzyme at the surface of the influenza virus particle. In
accord with this concept were the further observations that the inactivation
of purified ovarian cyst mucoid by influenza virus and by RDE, respec-
tively, under given conditions approximates a first order reaction, the rate
of reaction being proportional to the virus and RDE concentration respec-
tively, and that both agents have a pH optimum of 5.7 to 7.0.7 A further
outcome of the experimental results was the conclusion that the soluble
mucins inhibit haemagglutination by competing with the red cell receptors
for the influenza virus particle, that the cellular receptors and mucins have
some structural feature in common, and that it is this common grouping
which serves the viral enzyme and RDE as substrate.'
Over the past six years this laboratory has made an effort to establish by
chemical methods the activity of the viral enzyme, to elucidate the chemical
grouping attacked by the enzyme, and to throw some light on the mode of
the enzyme action. We restricted our work to the virus action on soluble
mucoids inhibiting virus haemagglutination since the preparation of cellular
receptors in quantity did not seem feasible, and in fact no electrophoretically
homogeneous preparation of red cell receptors has been obtained so far in
any laboratory. It was first shown that of the various components of hen
egg-white only the ovomucin fraction is able to inhibit haemagglutination
by heated influenza virus"8 and that the inhibitory power of ovomucin is
readily reduced both by living influenza virus and RDE.' From a reaction
mixture of ovomucin and a small amount of highly purified influenza A
virus, a dialysable compound was isolated consisting of carbohydrate and a
nitrogenous substance.' This compound, referred to as split product, had
quite unusual features. The carbohydrate was unstable even towards mild
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acid treatment (1.0 N HCl, 1000 C., 30 minutes) which caused formation
of considerable amounts of soluble and insoluble humin substances. The
nitrogenous component, after treatment with 0.1 N sodium carbonate for
12 minutes at 1000 C., coupled with p-dimethylaminobenzaldehyde (p-dab)
to give a purple colour identical with, but much more stable than, that
produced by an authentic specimen of N-acetyl D-glucosamine; spectro-
scopically the respective colouring matters exhibited the same adsorption
bands. However, in contrast to N-acetyl D-glucosamine the split product
was stable to prolonged heating at 1000 C. with 0.1 N sodium carbonate,
yet unstable towards mild acid treatment. After heating for few hours with
1.0 N HCl the compound failed to give a colour with p-dab even after ap-
propriate pretreatment with acetylacetone and alkali, whereas glucosamine
arising from the acid hydrolysis of N-acetyl D-glucosamine readily gives
the Ehrlich reaction after heating with acetylacetone in alkali. As in Hirst's
experiments with red cells and virus, so was shown in the assay with
ovomucin and virus that the virus, after reducing irreversibly the biological
activity of the mucoprotein by more than 95%, was available for inactiva-
tion of another quantity of native ovomucin. A compound with the same
properties was obtained when RDE instead of virus was taken as the
catalytic agent."
It was early recognised" that ovomucin is a protein fraction consisting
of the haemagglutinin inhibitory mucoprotein, one or more inert muco-
proteins, and a small proportion of lysozyme. That the formation of the
split product resulted from the interaction between living virus and the
inhibitory mucoprotein was shown by the following controls, none of which
yielded the dialyzable compound: (i) Heat-inactivated virus (550 C.; 30
minutes) and ovomucin; (ii) living virus and ovomucin, the inhibitory
portion of which had been removed by selective adsorption.'
Though at this stage the chemical identification of the split product was
unsatisfactory, its isolation did not leave any doubt as to the enzymic
nature of the reaction investigated and as to the site of the enzyme. There
is no other reasonable interpretation than that the enzyme is present at the
surface of the virus particle; indeed, it seems to form part of this surface
because it cannot be separated from the particle. That the enzyme is an
integral part of the influenza virus was showne by submitting the virus to
three independent purification procedures; though by these methods up to
99 per cent of the nitrogen of the crude virus preparation was removed,
the ratio haemagglutinin titre/enzymic activity remained unchanged.
Moreover, the enzyme is not present in the normal host cell.'
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When an electrophoretically homogeneous urine mucoprotein inhibiting
virus haemagglutination became available,"'87 corresponding experiments
with the pure material were carried out. It was gratifying to find'7 that
coinciding with the loss of its biological activity upon influenza virus B
action the pure urine mucoprotein released a dialyzable compound very
similar in properties to that liberated from ovomucin. The yield was about
1 per cent of the mucoprotein used, and weight for weight the split product
significantly exceeded in some assays the total virus used, the relevant
figures in one experiment, for instance, being 8.5 and 5.0 mg. respectively.
Examination of the split product revealed the presence of a single sugar and
of a nitrogenous component, most probably an amino-acid. The split
product, in its sensitivity towards mild acid treatment on heating, closely
resembled amino-acid N-glucosides and their isomers (N-substituted iso-
glucosamines) which we had synthesized18; in these condensation products,
e.g. between glucose and phenylalanine, the sugar moiety is readily trans-
formed into 5-(hydroxymethyl)-2-furaldehyde by 2 N acetic acid (1000 C.,
2 hours) probably by virtue of the basicity of the NHR group attached to
carbon atom one which favours the formation of the corresponding
conjugate acid.
The purple colour that the split product, after alkali treatment, gave with
p-dab remained unexplained since the properties described excluded N-acyl
hexosamine as component and since the synthetic condensation products did
not react with Ehrlich's reagent in the same manner. All observations
pointed to the presence in the enzymatically released product of a hitherto
unknown acid-labile and alkali-stable nitrogenous substance as being
responsible for the Ehrlich reaction. This conclusion was strongly sup-
ported by the findings of Odin'M that the split product reacted directly with
p-dab, i.e., without any pretreatment, and that this direct Ehrlich reaction
was also given by a number of influenza virus haemagglutinin inhibitory
mucins. Odin's report prompted an investigation in our laboratory into
the chemistry of the substance reacting directly with the p-dab reagent.
We have recently isolated's this substance from an electrophoretically
homogeneous inhibitory mucoprotein of bovine submaxillary glands and
identified it as 2-carboxy-pyrrole on the following evidence: (i) Authentic
2-carboxy-pyrrole, prepared according to Oddo,M and the unknown com-
ponent, obtained from the mucoprotein by mild alkali hydrolysis and
extraction of the hydrolysate with ethanol, gave similar purple colours with
p-dab instantly in the cold and for both the ninhydrin and Molisch reac-
tions were negative. (ii) Paper partition chromatography, using phenol,
butanol acetic acid, s-collidine, and butanol pyridine water, respectively, as
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solvent and Ehrlich reagent as spray, revealed identical RF values and
colour shade for both substances. (iii) Reduction of the two substances with
Adam's catalyst and hydrogen gas yielded a compound coinciding with DL-
proline in RF value and colour when run in the solvents mentioned and
sprayed with isatin. (iv) Both substances were found to have sharp absorp-
tion peaks in the ultraviolet at 263.5 m,. The pyrrole derivative prepared
from the mucoprotein has yet to be crystalled.
It may be mentioned that neither tryptophan nor any other known
protein component reacts with the Ehrlich reagent under the conditions
applied to give a purple colour. It seems, therefore, justified to correlate
the positive direct Ehrlich reaction, when carried out with mucoproteins or
portions thereof in 1.0 N HCI, with the presence in them of 2-carboxy-
pyrrole. On this assumption we found'2 the new imino-acid in the homo-
geneous inhibitory mucoproteins from human urine' and sputum,' from
bovine and sheep submaxillary glands,' in the non-inhibitory pure muco-
protein from human plasma,3"45 in the non-inhibitory ovomucoid, in the
ovomucin fraction, and in the glycoproteins casein and ox-serum albumin.
The imino-acid is not present in carbohydrate-free proteins like insulin and
globin (from haemoglobin), nor could it be traced in the mucopolysaccha-
rides heparin and hyaluronic acid, both of which contain hexuronic acid.'
We could confirm Odin's observation that the split product gives the
direct Ehrlich reaction. This quality taken together with the other proper-
ties of the split product,'7 namely, the positive Molisch test, its reducing
power in alkali medium, its nitrogen content, the instability towards mild
acid treatment both of the sugar moiety and of the component coupling
directly with p-dab, and the alkali stability of the latter is best explained
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The alkali stability of pyrrole and the instability of pyrrole carboxylic acid
towards acid are known, and the humin formation of the split product upon
heating with 1.0 N HCI is closely imitated by a mixture of 2-carboxy-
pyrrole and a reducing hexose or pentose when submitted to the same
conditions.'
Recently Klenk and Lauensteinhla have prepared from bovine submaxil-
lary glands and from human urine the crystalline methoxy derivative of
"neuraminic acid"; the analytical data from the crystalline material are in
close agreement with the formula C11H2109N; its structure is unknown.
Neuraminic acid resembles the split product in its reducing power, its direct
reaction with Ehrlich's reagent, and in its strong humin formation on
heating with dilute mineral acid. If, as the authors assume, the two com-









Structure II is the Amadori rearranged isomer of structure I. The methoxy
derivative of structure II would have the formula C11H2109N, when the
compound crystallizes with three molecules of water.
Treatment of cellular receptors and inhibitory mucoproteins with periodic
acid at low concentration modifies within a short time these substances in
such a way as to make them no longer a suitable substrate for the viral
enzyme."" "' This modification was ascribed to the well-known oxidation
of a-glycol groups in carbohydrates and interpreted to mean that the carbo-
hydrate moiety of mucoproteins is the preferential site of attack by the viral
enzyme. The presence in the split product of a carbohydrate strengthened
this view. An analysis for carbohydrate components of the acid hydrolysate
of the homogeneous urine mucoprotein was, therefore, carried out'9 with
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the following result: 5.4 per cent galactose, 2.7 per cent mannose, 1.0 per
cent fucose, and 7.6 per cent hexosamine; the hexosamine present was
shown to be a mixture of glucosamine and galactosamine. Odin,' in an
independent investigation on the same subject, reported the following
figures: 8.1 per cent total hexose (galactose and mannose), 1.0 per cent
fucose, and 7.6 per cent hexosamine. As mentioned above, the urine muco-
protein also contains 2-carboxy-pyrrole, the quantitative estimate amounting
to about 4 per cent. By treatment of the inhibitor with 10 per cent barium
hydroxide at 1000 C. for several hours, the carbohydrate moiety may be
separated from the bulk of the protein. On acid hydrolysis the polysac-
charide yielded galactose, mannose, fucose, and hexosamine in proportions
similar to those quoted above for the acid hydrolysate of the total muco-
protein."9"21 In addition to the sugars the polysaccharide contained the imino-
acid.'2 In order to obtain some information about the size of the polysac-
charide, the compound after separation from the protein by alkali treatment
was submitted to dialysis through a cellophane membrane with lysozyme
(molecular weight 16,000) as control. The polysaccharide dialysed slowly
through a membrane of a pore size which allowed lysozyme to pass to a
minute degree only.'
The composition of the polysaccharide, assuming that about 75% of the
total 2-carboxy-pyrrole are incorporated in it,, may be summarized as
follows:
6 galactose residues 1
3 mannose residues molecular weight
1 fucose residue (3488)n
8 hexosamine residues where n < 5
5 2-carboxy-pyrrole residues
The molecular weight of the polysaccharide, assuming that 3 hexosamine
residues (see below) are N-acetylated, is about (3500)n. The dialyzability
through a cellophane membrane retaining lysozyme would suggest that n is
not more than three or four. We regard' the mixed polysaccharide of a
molecular weight of the order of 10,000 as an individual prosthetic group
and visualize the mucoprotein as a conjugated protein containing as pros-
thetic group a relatively small polysaccharide; about 150 of such poly-
saccharides may be linked to each protein on the basis of a molecular
weight" of 7 x 106 for the urine mucoprotein and of a carbohydrate content
including 2-carboxy-pyrrole of about 20 per cent. The concept of multiple
small-sized carbohydrate prosthetic groups accounts much better for the
biological and biophysical data than the presence in the mucoprotein of a
359YALE JOURNAL OF BIOLOGY AND MEDICINE
giant polysaccharide, molecular weight 1.4 x 106, linked through a single
bond with the protein moiety.
It seems of interest that the carbohydrate complex (prosthetic group) of
the electrophoretically homogeneous inhibitory mucoprotein prepared from
human sputum consists of galactose, fucose, hexosamine, and 2-carboxy-
pyrrole.'
There is some indication that the polysaccharide in the inhibitory urine
mucoprotein is of a branched structure. Assuming the presence in the muco-





CC OCt 0 HCOH
N -H
I HCOH Tail of the prosthetlc
1 4>0 group
I
FIG. 1. Showing the viral enzyme susceptible bond between the carboxyl of pyrrole
and the amino group of the D-galactosamine.
of linear polysaccharides and an average molecular weight of the split
product (N-glycosyl-2-carboxy-pyrrole) of 250, the removal by viral
enzyme action of even all the terminal N-glycosyl-2-carboxy-pyrrole group-
ings would account for a yield of not more than 0.5 per cent referred to dry
matter of the substrate added. The experimental yield on split product,
however, is about 1 per cent. It seems, therefore, more likely that the
polysaccharide is of the branched type having perhaps three or four terminal
N-glycosyl-2-carboxy-pyrrole groups. It may well be that the degree of
branching is one of the factors determining the affinity between a given
strain of influenza virus and the various inhibitory mucoproteins having
polysaccharides of similar composition.
With regard to the linkage of 2-carboxy-pyrrole within the prosthetic
group of the inhibitory urine mucoprotein it is suggested's that its carbonyl
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carbon forms an amide bond with the nitrogen of an adjacent hexosamine,
and that the pyrrole nitrogen engages in a glycosidic linkage with a sugar
residue. The pyrrole nitrogen has no basic property; hence, if the viral
enzyme be an amidase (see Fig. 1), breaking the susceptible carbon-
nitrogen bond, its action will add a positive charge to the residual muco-
protein not counterbalanced by an equivalent loss in the split product. In
fact, it has been shown by Horsfallr for the urine mucoprotein and by Pye
in this Institute for all inhibitory mucoproteins prepared so far in a homo-
geneous state that their net negative charge sharply decreases after treat-
ment with influenza virus or with RDE, as it was previously found for the
red cells.' This decrease in net negative charge could be due to either the
loss of a negatively charged group or the unmasking of a positively charged
one. Recent acid-base titrations showed that amino groups of pK value 10.8
to 11.2 are uncovered by the action of Lee influenza virus or RDE on urine
mucoprotein.'
From the reported results it may be concluded that the influenza virus
is equipped with an enzyme the substrate of which is the prosthetic group
(polysaccharide) of a conjugated protein. There are two or more enzymati-
cally active spots at the virus surface spaced in such a way as to fit the
terminal groupings of a heterogeneous, probably branched, polysaccharide.
The polysaccharide consists of hexoses, methylpentose, hexosamines, and
2-carboxyl-pyrrole. There is good evidence that the compound released by
viral enzyme action from the prosthetic group of the inhibitory urine muco-
protein consists of 2-carboxy-pyrrole and a single sugar linked probably in
an N-glycosidic fashion, and there is some indication that the susceptible
bond is an amide link between the carbonyl group of the pyrrole derivative
and the amino group of an adjacent hexosamine.
No definite statement can be made about the manner in which the poly-
saccharide is joined to the matrix of the protein. It is tempting to speculate
that the imino-acid 2-carboxy-pyrrole is present not only at the free end of
the prosthetic group but provides also the chemical link between the amino
group of a polypeptide and the reducing end of the polysaccharide, its
carboxyl group forming a peptide bond with the amino group of an amino-
acid and its nitrogen engaging the reducing carbon of the polysaccharide in
a glycosidic linkage. This suggestion would account for the presence of the
imino-acid in neutral mucoproteins and its absence in carbohydrate-free
mucoproteins and in mucopolysaccharides containing acidic sugar deriva-
tives; moreover, it would bring the carbohydrate-protein link in line with
the type of bond joining in nucleosides and co-enzymes the pentose or
desoxypentose component with the respective purine, pyrimidine, and pyri-
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dine derivative. In all these natural compounds the basic nitrogen of a
heterocyclic ring engages the 5 carbon sugar in a N-glycosidic linkage; it
may be of interest in this context that some pyrrole derivatives react
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